First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)-Reference-Cited by-同舟云学术

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)

Published:2012-11-02 Issue:2 Volume:207 Page:240-247
ISSN:1537-6613
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Baden Lindsey R.,Walsh Stephen R.,Seaman Michael S.,Tucker Robert P.,Krause Kathleen H.,Patel Alka,Johnson Jennifer A.,Kleinjan Jane,Yanosick Katherine E.,Perry James,Zablowsky Elise,Abbink Peter,Peter Lauren,Iampietro M. Justin,Cheung Ann,Pau Maria G.,Weijtens Mo,Goudsmit Jaap,Swann Edith,Wolff Mark,Loblein Hayley,Dolin Raphael,Barouch Dan H.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/207/2/240/16866590/jis670.pdf

Reference28 articles.

1. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;Buchbinder;Lancet,2008

2. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis;McElrath;Lancet,2008

3. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;Rerks-Ngarm;N Engl J Med,2009

4. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection;Flynn;J Infect Dis,2005

5. Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects;Baden;J Infect Dis,2011

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trials and recent progress in HIV vaccine development;Functional & Integrative Genomics;2024-08-28

2. Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview;Heliyon;2024-08

3. Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV;Vaccines;2024-06-09

4. A Randomized, Double‐Blind, Placebo‐Controlled, Phase 1 Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Single Vaccination of Ad26.RSV.preF‐Based Regimen in Japanese Adults Aged 60 Years and Older;Influenza and Other Respiratory Viruses;2024-06

5. The Question of HIV Vaccine: Why Is a Solution Not Yet Available?;Journal of Immunology Research;2024-04-08